Actinium Pharmaceuticals Depreciation & Amortization 2011-2026 | ATNM

Annual Depreciation & Amortization Actinium Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
173 K	197 K	207 K	699 K	524 K	447 K	420 K	50.7 K	55.9 K	77.5 K	53.5 K	37.9 K	1.56 K	581	633

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
699 K	581	196 K

Quarterly Depreciation & Amortization Actinium Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	205 K	-	-	-	216 K	-	-	-	182 K	-	538 K	317 K	137 K	-	387 K	254 K	125 K	-	327 K	216 K	108 K	-	316 K	209 K	104 K	-	38.1 K	24.8 K	12 K	-	11 K	14.3 K	20.9 K	-	57.7 K	37.6 K	18.1 K	-	43.4 K	26.6 K	10.4 K	-	14.3 K	8.05 K	1.4 K	-	-	-	-	-	429	317	158	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
538 K	158	121 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	31.6 M	$ 21.94	2.48 %	$ 1.03 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.9	0.49 %	$ 6.62 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.66	3.19 %	$ 3.76 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.14	1.35 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.58	1.38 %	$ 3 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	8.3 M	$ 1.44	-0.35 %	$ 383 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.92	-0.45 %	$ 4.81 M	Israel
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	154 K	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	364 K	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	300 K	$ 1.1	3.77 %	$ 13.4 M	USA
Cabaletta Bio CABA	1.65 M	$ 2.99	1.19 %	$ 300 M	USA
Cara Therapeutics CARA	95 K	-	-3.03 %	$ 260 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	468 K	-	-	$ 35.4 M	USA
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA